Medicomp
Medicomp, operating as Pivotal Health (formerly ReactDx), develops and operates ambulatory cardiac monitoring systems (TelePatch MCT/Holter) and home sleep testing services (NiteWatch), serving cardiology and sleep medicine practices and credentialed US hospitals using its patented Diogenes analysis algorithm.
- Company typePrivate
- Founded1981
- HeadquartersMelbourne, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Medicomp does
Medicomp, Inc. — now operating commercially under the Pivotal Health brand (formerly ReactDx) — is a privately held medical device and diagnostic-services company headquartered in Melbourne, Florida, founded in 1981 and employing between 101 and 250 people. The company develops, manufactures, and operates ambulatory cardiac monitoring systems, including the TelePatch family of mobile cardiac telemetry (MCT) and Extended Holter devices, alongside home sleep testing (HST) services under the NiteWatch brand. Its diagnostic output is generated through the proprietary, patented Diogenes beat-to-beat analysis algorithm, which delivers what the company reports as 99.9% notification accuracy and includes P-wave detection capability.
Medicomp's commercial model is a hybrid of service revenue and partner-distributed hardware. The core economic engine is recurring per-study fees billed to prescribing physicians and institutions for cardiac monitoring and HST interpretation services rendered through the company. Under the Pivotal Health positioning, Medicomp has extended this model into sleep therapy hardware through a distribution partnership with React Health for the LUNA G3 PAP device, enabling an end-to-end screen-to-treat pathway for obstructive sleep apnea. Customer-facing infrastructure is delivered through the RDxOne physician portal, which is integrated into external electronic medical record (EMR) systems at no incremental charge, embedding ordering, report delivery, and notifications into clinician workflows.
The customer base is composed primarily of cardiology and sleep medicine practices, with hospitals and health systems representing a credentialed institutional segment enabled by Joint Commission Gold Seal and ACHC accreditation. Pricing is not publicly listed and is structured on a quote or contract basis for monitoring services and hardware bundles. Medicomp is led by President and COO Tony Balda and Chief Medical Officer Jay Anders, and operates exclusively within the United States.
Medicomp firmographics
Firmographics- Name
- Medicomp
- Legal name
- Medicomp, Inc.
- Website
- https://medicompinc.com
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Medicomp, operating as Pivotal Health (formerly ReactDx), develops and operates ambulatory cardiac monitoring systems (TelePatch MCT/Holter) and home sleep testing services (NiteWatch), serving cardiology and sleep medicine practices and credentialed US hospitals using its patented Diogenes analysis algorithm.
- Ownership category
- akta.pro rank
Medicomp industry classification
Industry- Product category
- Ambulatory Cardiac Diagnostics
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Home Health Care Services (62161), Offices of Physicians (6211)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB), Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA), Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)
Keywords
Where Medicomp is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Medicomp business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Cardiac Monitoring Services: Mobile Cardiac Telemetry (MCT) and Extended Holter monitoring services providing diagnostic data to healthcare providers with rapid report turnaround
- Home Sleep Testing Services: End-to-end sleep apnea diagnostic services including home sleep testing (HST) with board-certified sleep physician interpretation
- Sleep Therapy Products: LUNA G3 PAP devices and related sleep therapy equipment for patients transitioning from diagnosis to treatment
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Monthly | Cardiac Monitoring - TelePatch MCT |
| Other | Monthly | Extended Holter Monitoring |
| Other | Monthly | Home Sleep Testing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Medicomp product offering
Product offeringCore offering
Medicomp develops, manufactures, and delivers ambulatory cardiac and sleep apnea diagnostic monitoring services for medical professionals. Its core offerings include Mobile Cardiac Telemetry and Extended Holter monitoring via the proprietary TelePatch dual-channel patch, home sleep apnea testing through the NiteWatch device interpreted by board-certified sleep physicians, and an RDxOne/ReactOne physician portal with free EMR integration for workflow and reporting.
Product overview
Medicomp, Inc. dba ReactDx operates as a diagnostic services company offering a unified portfolio of cardiac monitoring and sleep apnea testing solutions. The core product line includes TelePatch for Mobile Cardiac Telemetry (MCT) and TelePatch for Extended Holter monitoring, both utilizing a proprietary two-channel patch system. Sleep diagnostics are anchored by NiteWatch home sleep testing and the LUNA G3 PAP therapy devices in partnership with React Health. All diagnostic data flows through the RDxOne physician portal and ReactOne reporting platform, with the Diogenes patented algorithm powering ECG beat analysis. The company also provides free EMR integration for simplified workflow onboarding.
Differentiator
Problem solved
Functional benefit
Brands
- TelePatch: Industry-leading dual-channel patch for Mobile Cardiac Telemetry (MCT) and Extended Holter monitoring
- NiteWatch
- LUNA G3
Products and services
- TelePatch for Mobile Cardiac Telemetry (MCT) Ambulatory cardiac monitor providing Mobile Cardiac Telemetry services to medical professionals using a proprietary two-channel patch for real-time ECG monitoring, arrhythmia detection, and rapid notification delivery.
- TelePatch for Extended Holter Extended Holter monitoring service using a dual-channel patch that provides two separate, distinct, and comparative views of the patient's ECG for ambulatory cardiac rhythm analysis.
- NiteWatch Home Sleep Apnea Testing Home sleep apnea testing device that measures six distinct channels (SpO2, photoplethysmogram, pulse rate, airflow, respiratory effort, and heart rate variability) with clinical accuracy comparable to sleep-lab testing.
- Home Sleep Testing (HST) Service End-to-end home sleep apnea diagnostic service with studies interpreted by board-certified sleep physicians, delivering results in days rather than weeks and enabling transition to appropriate sleep therapy.
- RDxOne / ReactOne Physician Portal Clinical portal and patient management platform that enables physicians to enroll patients, review diagnostic reports, electronically sign reports, and manage cardiac and sleep testing workflow.
Quantifiable outcome
- 99.9% notification accuracy with 1-hour urgent patient notification delivery
- +2 more outcomes
Companies that use Medicomp
Customer profileSegments2 records
Ideal customer profiles2 records
Medicomp technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
Medicomp partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- React HealthcoreReactDx and React Health created a complete end-to-end solution combining expertise in sleep and cardiac diagnostic services with the complete line of industry-leading LUNA G3 PAP (Positive Airway Pressure) devices. This partnership enables transition from diagnosis to appropriate sleep therapy.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
Medicomp competitors and assessment
Company assessmentDirect peers
- Itamar Medical (ZOLL Itamar): Sleep apnea diagnostics company acquired by ZOLL Medical, maker of WatchPAT home sleep testing devices. Direct competitor to Medicomp's NiteWatch HST service in the same cardiology-channel sleep apnea screening market.
- iRhythm Technologies: Direct competitor in ambulatory cardiac monitoring with the Zio patch for MCT and Holter-style diagnostics. Closest analog to Medicomp's TelePatch offering in target customers (physicians, cardiologists) and business model (diagnostic service plus wearable).
- BioSerenity: French-headquartered cardiac and sleep diagnostic company; produces wearable ECG and PSG/HST devices and operates diagnostic services. Comparable as a multi-modality remote monitoring peer and already known to Medicomp via the LUNA G3 partnership.
- Preventice Solutions (Boston Scientific): Acquired by Boston Scientific in 2021, Preventice offers BodyGuardian remote cardiac monitoring (MCT, Holter, event monitoring) directly competitive with TelePatch. Comparable in patient population, physician channel, and service-based revenue model.
- Bardy Diagnostics (Baxter / Hillrom): Acquired by Hillrom (now Baxter), BardyDx offered the Carnation Ambulatory Monitor patch for ambulatory ECG. Direct competitor in the wearable cardiac patch category targeting the same cardiologist and electrophysiologist customers.
Broad incumbents
- Medtronic: Broad incumbent in cardiac diagnostics and monitoring (LINQ insertable cardiac monitor, Reveal family, SEEQ MCT). Comparable across Medicomp's cardiac monitoring use cases with much greater scale and hospital system reach.
- ResMed: Global leader in sleep-disordered breathing and PAP therapy (AirSense, AirCurve). Comparable as a broad incumbent in the downstream sleep therapy half of Medicomp's diagnostic-to-therapy pathway, with much larger scale and direct-to-patient reach.
- Philips (formerly BioTelemetry): Philips acquired BioTelemetry and now operates a leading ambulatory cardiac monitoring franchise alongside broader sleep diagnostics (Alice PSG, DreamMapper). Larger incumbent with overlapping MCT, Holter, and sleep diagnostic offerings to hospital and physician customers.
Emerging players
- React Health: Manufacturer of LUNA G3 PAP and other sleep therapy/respiratory devices; strategic partner of Medicomp for sleep therapy. Comparable as a sleep therapy hardware vendor that bridges diagnostics and treatment in the same end-to-end workflow Medicomp aspires to.
Regional players
- Spacelabs Healthcare: Sleep diagnostics (in-lab PSG and HST) and patient monitoring vendor; serves hospital and IDN channels. Comparable on the sleep diagnostics side of Medicomp's portfolio, with stronger lab-based PSG presence but overlapping HST capability.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Medicomp social profiles
Digital presenceMedicomp compliance and trust
Trust signalCompliance2 records
Medicomp financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medicomp leadership team
Management profileNumber of profiles
Profiles2 records
Medicomp funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medicomp M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medicomp
What does Medicomp do?
Medicomp develops, manufactures, and delivers ambulatory cardiac and sleep apnea diagnostic monitoring services for medical professionals. Its core offerings include Mobile Cardiac Telemetry and Extended Holter monitoring via the proprietary TelePatch dual-channel patch, home sleep apnea testing through the NiteWatch device interpreted by board-certified sleep physicians, and an RDxOne/ReactOne physician portal with free EMR integration for workflow and reporting.
When was Medicomp founded?
Medicomp was founded in 1981. It employs 101 to 250 people.
Where is Medicomp based?
Medicomp is headquartered in Melbourne, United States, in the North America region.
How does Medicomp make money?
Three revenue lines are on record. Cardiac Monitoring Services are the primary driver. The others are home Sleep Testing Services and sleep Therapy Products.
Who are Medicomp's main competitors?
Direct peers on record are Itamar Medical (ZOLL Itamar), iRhythm Technologies, BioSerenity, Preventice Solutions (Boston Scientific) and Bardy Diagnostics (Baxter / Hillrom). Broad incumbents are Medtronic, ResMed and Philips (formerly BioTelemetry). React Health is listed as an emerging player. Spacelabs Healthcare is listed as a regional player.
Does Medicomp have an API?
No public API is recorded for Medicomp.
What industry is Medicomp in?
Medicomp's product category is Ambulatory Cardiac Diagnostics. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3841.